FDA Inspection
Dipharma Francis SrlDipharma Francis Srl – FDA Inspection, Apr 28, 2017
Record Details
This FDA Inspection record concerns Dipharma Francis Srl, with an inspection on April 28, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6ac18949-807b-4548-8f8c-f0fd29b2e8bc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1019767
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Dipharma Francis Srl
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 25, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 20, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 7, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 20, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Dipharma Francis Srl
- FDA Inspection 1202251 - 2022-02-25
- FDA Inspection 1126904 - 2018-04-20
- FDA Inspection 871282 - 2014-03-07
- FDA Inspection 705342 - 2010-12-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.